Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ADP-ribosylation factor-like 2 binding protein pseudogene, identified by the Ensembl gene ID ENSG00000259608, is a sequence in the human genome that closely resembles the functional gene encoding the ADP-ribosylation factor-like 2 binding protein, but lacks the ability to produce a functional protein product. Pseudogenes typically arise by gene duplication or retrotransposition, and accumulate disabling mutations such as premature stops or frameshifts that render them noncoding. While a small number of pseudogenes can be transcribed or produce regulatory RNA, this is uncommon and no specific function or clinical significance is documented for ENSG00000259608. Pseudogenes like this one are not considered therapeutic targets, receptors, or biomarkers, and are primarily relevant in genomics as nonfunctional evolutionary remnants or possible sources of regulatory sequences.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADP-ribosylation factor-like 2 binding protein pseudogene.